Novartis AG (NVSEF) stock

NVSEFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVS

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30

$146.46+2.56 (+1.78%)

Close on Oct 19, 2026Market cap $279.46BP/E 20.5Yield –

Novartis price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Novartis has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?